Anthera Pharmaceuticals, Inc. (ANTH) said Wednesday that it plans to offer and sell shares of its common stock in an underwritten public offering.
The company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any.
The company said it plans to use the net proceeds from the offering for general corporate purposes.
Anthera said offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Piper Jaffray & Co. and Leerink Swann LLC are acting as joint book-running managers in the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.